Drug Profile
Didemnin B
Alternative Names: NSC 325319Latest Information Update: 01 Aug 2000
Price :
$50
*
At a glance
- Originator University of Illinois
- Class Antineoplastics; Depsipeptides
- Mechanism of Action DNA synthesis inhibitors; Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Brain cancer; Cancer; Malignant melanoma; Non-Hodgkin's lymphoma